- Home
- SHLT vs OKYO Comparison
SHLT vs OKYO Comparison
Compare SHLT & OKYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHLT
- OKYO
- Stock Information
- Founded
- SHLT 1987
- OKYO 2007
- Country
- SHLT Israel
- OKYO United Kingdom
- Employees
- SHLT N/A
- OKYO N/A
- Industry
- SHLT Business Services
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHLT Consumer Discretionary
- OKYO Health Care
- Exchange
- SHLT Nasdaq
- OKYO Nasdaq
- Market Cap
- SHLT 39.3M
- OKYO 37.0M
- IPO Year
- SHLT N/A
- OKYO 2022
- Fundamental
- Price
- SHLT $2.02
- OKYO $1.22
- Analyst Decision
- SHLT
- OKYO Strong Buy
- Analyst Count
- SHLT 0
- OKYO 1
- Target Price
- SHLT N/A
- OKYO $7.00
- AVG Volume (30 Days)
- SHLT 9.5K
- OKYO 134.7K
- Earning Date
- SHLT 04-24-2025
- OKYO 04-15-2025
- Dividend Yield
- SHLT N/A
- OKYO N/A
- EPS Growth
- SHLT N/A
- OKYO N/A
- EPS
- SHLT N/A
- OKYO N/A
- Revenue
- SHLT $55,939,000.00
- OKYO N/A
- Revenue This Year
- SHLT N/A
- OKYO N/A
- Revenue Next Year
- SHLT N/A
- OKYO N/A
- P/E Ratio
- SHLT N/A
- OKYO N/A
- Revenue Growth
- SHLT N/A
- OKYO N/A
- 52 Week Low
- SHLT $1.85
- OKYO $0.81
- 52 Week High
- SHLT $6.73
- OKYO $1.74
- Technical
- Relative Strength Index (RSI)
- SHLT 38.63
- OKYO 44.36
- Support Level
- SHLT $1.85
- OKYO $1.17
- Resistance Level
- SHLT $2.57
- OKYO $1.48
- Average True Range (ATR)
- SHLT 0.27
- OKYO 0.10
- MACD
- SHLT -0.04
- OKYO -0.03
- Stochastic Oscillator
- SHLT 22.67
- OKYO 11.89
About SHLT SHL Telemedicine Ltd
SHL Telemedicine Ltd develops and markets personal telemedicine solutions. It consists of the transmission of medical data by an individual, from a remote location to a medical call center through telecommunication networks. The company offers solutions to subscribing patients, health insurance companies, hospitals, clinics, and physicians. It provides healthcare professional solutions to patients suffering from congestive heart failure, chronic obstructive pulmonary disease, and readmission solutions for reducing heart-related readmissions. In addition, consumer solutions include cardiac monitoring services. The company's geographical segments Israel, Europe, and the rest of the world, out of which majority revenue comes from Israel.
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.